401k Plan data: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN plan

UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 401k Plan overview

Plan Name	UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN
Plan identification number	001

UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

UNITED THERAPEUTICS CORPORATION has sponsored the creation of one or more 401k plans.

Company Name: UNITED THERAPEUTICS CORPORATION

Employer identification number (EIN): 521984749

NAIC Classification: 541700

Additional information about UNITED THERAPEUTICS CORPORATION

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 2638178

More information about UNITED THERAPEUTICS CORPORATION

Form 5500 Filing Information

Submission information for form 5500 for 401k plan UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2023-01-01
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 ALYSSA FRIEDRICH
001 2016-01-01 ALYSSA FRIEDRICH ALYSSA FRIEDRICH 2017-09-25
001 2015-01-01 ALYSSA FRIEDRICH ALYSSA FRIEDRICH 2016-07-18
001 2014-01-01 ALYSSA FRIEDRICH
001 2013-01-01 ALYSSA FRIEDRICH ALYSSA FRIEDRICH 2014-07-02
001 2012-01-01 ALYSSA FRIEDRICH
001 2011-01-01 ALYSSA FRIEDRICH ALYSSA FRIEDRICH 2012-07-31
001 2010-01-01 ALYSSA FRIEDRICH
001 2009-01-01 ALYSSA FRIEDRICH

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2023-01-01
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	ALYSSA FRIEDRICH
001	2016-01-01	ALYSSA FRIEDRICH	ALYSSA FRIEDRICH	2017-09-25
001	2015-01-01	ALYSSA FRIEDRICH	ALYSSA FRIEDRICH	2016-07-18
001	2014-01-01	ALYSSA FRIEDRICH
001	2013-01-01	ALYSSA FRIEDRICH	ALYSSA FRIEDRICH	2014-07-02
001	2012-01-01	ALYSSA FRIEDRICH
001	2011-01-01	ALYSSA FRIEDRICH	ALYSSA FRIEDRICH	2012-07-31
001	2010-01-01	ALYSSA FRIEDRICH
001	2009-01-01	ALYSSA FRIEDRICH

Plan Statistics for UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN

401k plan membership statisitcs for UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN

Measure Date Value
2023: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2023 401k membership
Total participants, beginning-of-year 2023-01-01 1,238
Total number of active participants reported on line 7a of the Form 5500 2023-01-01 1,091
Number of retired or separated participants receiving benefits 2023-01-01 0
Number of other retired or separated participants entitled to future benefits 2023-01-01 275
Total of all active and inactive participants 2023-01-01 1,366
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2023-01-01 1
Total participants 2023-01-01 1,367
Number of participants with account balances 2023-01-01 1,344
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2023-01-01 28
2022: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,199
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 974
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 264
Total of all active and inactive participants 2022-01-01 1,238
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 1,238
Number of participants with account balances 2022-01-01 1,212
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 35
2021: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,149
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 967
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 232
Total of all active and inactive participants 2021-01-01 1,199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 1,199
Number of participants with account balances 2021-01-01 1,177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 30
2020: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,116
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 944
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 205
Total of all active and inactive participants 2020-01-01 1,149
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 1,149
Number of participants with account balances 2020-01-01 1,124
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 21
2019: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,046
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 908
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 208
Total of all active and inactive participants 2019-01-01 1,116
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 1,116
Number of participants with account balances 2019-01-01 1,092
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 41
2018: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 959
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 838
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 208
Total of all active and inactive participants 2018-01-01 1,046
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 1,046
Number of participants with account balances 2018-01-01 998
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 38
2017: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 885
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 782
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 177
Total of all active and inactive participants 2017-01-01 959
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 959
Number of participants with account balances 2017-01-01 935
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 17
2016: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 839
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 722
Number of other retired or separated participants entitled to future benefits 2016-01-01 162
Total of all active and inactive participants 2016-01-01 884
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 885
Number of participants with account balances 2016-01-01 855
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 28
2015: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 803
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 702
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 137
Total of all active and inactive participants 2015-01-01 839
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 839
Number of participants with account balances 2015-01-01 804
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 28
2014: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 743
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 699
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 104
Total of all active and inactive participants 2014-01-01 803
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 803
Number of participants with account balances 2014-01-01 764
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 27
2013: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 656
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 665
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 77
Total of all active and inactive participants 2013-01-01 742
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 742
Number of participants with account balances 2013-01-01 686
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 20
2012: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 611
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 581
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 75
Total of all active and inactive participants 2012-01-01 656
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 656
Number of participants with account balances 2012-01-01 592
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 26
2011: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 567
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 560
Number of other retired or separated participants entitled to future benefits 2011-01-01 51
Total of all active and inactive participants 2011-01-01 611
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 611
Number of participants with account balances 2011-01-01 468
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 13
2010: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 431
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 525
Number of retired or separated participants receiving benefits 2010-01-01 0
Number of other retired or separated participants entitled to future benefits 2010-01-01 37
Total of all active and inactive participants 2010-01-01 562
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 562
Number of participants with account balances 2010-01-01 366
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 6
2009: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 374
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 381
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 43
Total of all active and inactive participants 2009-01-01 424
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 424
Number of participants with account balances 2009-01-01 307
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 10

Measure	Date	Value
2023: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2023 401k membership
Total participants, beginning-of-year	2023-01-01	1,238
Total number of active participants reported on line 7a of the Form 5500	2023-01-01	1,091
Number of retired or separated participants receiving benefits	2023-01-01	0
Number of other retired or separated participants entitled to future benefits	2023-01-01	275
Total of all active and inactive participants	2023-01-01	1,366
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2023-01-01	1
Total participants	2023-01-01	1,367
Number of participants with account balances	2023-01-01	1,344
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2023-01-01	28
2022: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,199
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	974
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	264
Total of all active and inactive participants	2022-01-01	1,238
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	1,238
Number of participants with account balances	2022-01-01	1,212
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	35
2021: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,149
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	967
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	232
Total of all active and inactive participants	2021-01-01	1,199
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	1,199
Number of participants with account balances	2021-01-01	1,177
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	30
2020: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,116
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	944
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	205
Total of all active and inactive participants	2020-01-01	1,149
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	1,149
Number of participants with account balances	2020-01-01	1,124
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	21
2019: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,046
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	908
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	208
Total of all active and inactive participants	2019-01-01	1,116
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	1,116
Number of participants with account balances	2019-01-01	1,092
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	41
2018: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	959
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	838
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	208
Total of all active and inactive participants	2018-01-01	1,046
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	1,046
Number of participants with account balances	2018-01-01	998
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	38
2017: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	885
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	782
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	177
Total of all active and inactive participants	2017-01-01	959
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	959
Number of participants with account balances	2017-01-01	935
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	17
2016: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	839
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	722
Number of other retired or separated participants entitled to future benefits	2016-01-01	162
Total of all active and inactive participants	2016-01-01	884
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	885
Number of participants with account balances	2016-01-01	855
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	28
2015: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	803
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	702
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	137
Total of all active and inactive participants	2015-01-01	839
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	839
Number of participants with account balances	2015-01-01	804
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	28
2014: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	743
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	699
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	104
Total of all active and inactive participants	2014-01-01	803
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	803
Number of participants with account balances	2014-01-01	764
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	27
2013: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	656
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	665
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	77
Total of all active and inactive participants	2013-01-01	742
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	742
Number of participants with account balances	2013-01-01	686
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	20
2012: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	611
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	581
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	75
Total of all active and inactive participants	2012-01-01	656
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	656
Number of participants with account balances	2012-01-01	592
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	26
2011: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	567
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	560
Number of other retired or separated participants entitled to future benefits	2011-01-01	51
Total of all active and inactive participants	2011-01-01	611
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	611
Number of participants with account balances	2011-01-01	468
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	13
2010: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	431
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	525
Number of retired or separated participants receiving benefits	2010-01-01	0
Number of other retired or separated participants entitled to future benefits	2010-01-01	37
Total of all active and inactive participants	2010-01-01	562
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	562
Number of participants with account balances	2010-01-01	366
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	6
2009: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	374
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	381
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	43
Total of all active and inactive participants	2009-01-01	424
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	424
Number of participants with account balances	2009-01-01	307
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	10

Financial Data on UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN

Measure	Date	Value
2023 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2023 401k financial data
Total income from all sources (including contributions)	2023-12-31	$66,595,773
Total of all expenses incurred	2023-12-31	$13,638,804
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2023-12-31	$13,483,674
Value of total corrective distributions	2023-12-31	$8,812
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2023-12-31	$26,639,913
Value of total assets at end of year	2023-12-31	$238,899,320
Value of total assets at beginning of year	2023-12-31	$185,942,351
Total of administrative expenses incurred including professional, contract, advisory and management fees	2023-12-31	$146,318
Total interest from all sources	2023-12-31	$90,941
Total dividends received (eg from common stock, registered investment company shares)	2023-12-31	$1,146,212
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2023-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2023-12-31	$1,146,212
Was this plan covered by a fidelity bond	2023-12-31	Yes
Value of fidelity bond cover	2023-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2023-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2023-12-31	No
Contributions received from participants	2023-12-31	$17,597,862
Participant contributions at end of year	2023-12-31	$1,585,034
Participant contributions at beginning of year	2023-12-31	$1,552,587
Income. Received or receivable in cash from other sources (including rollovers)	2023-12-31	$2,492,858
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Value of net income/loss	2023-12-31	$52,956,969
Value of net assets at end of year (total assets less liabilities)	2023-12-31	$238,899,320
Value of net assets at beginning of year (total assets less liabilities)	2023-12-31	$185,942,351
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2023-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2023-12-31	No
Were any leases to which the plan was party in default or uncollectible	2023-12-31	No
Investment advisory and management fees	2023-12-31	$44,752
Value of interest in registered invesment companies (eg mutual funds) at end of year	2023-12-31	$81,332,642
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2023-12-31	$91,180,638
Interest on participant loans	2023-12-31	$90,941
Value of interest in common/collective trusts at end of year	2023-12-31	$155,981,644
Value of interest in common/collective trusts at beginning of year	2023-12-31	$93,207,670
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2023-12-31	$19,449,628
Net investment gain or loss from common/collective trusts	2023-12-31	$19,269,079
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2023-12-31	No
Was there a failure to transmit to the plan any participant contributions	2023-12-31	No
Has the plan failed to provide any benefit when due under the plan	2023-12-31	No
Contributions received in cash from employer	2023-12-31	$6,549,193
Employer contributions (assets) at end of year	2023-12-31	$0
Employer contributions (assets) at beginning of year	2023-12-31	$1,456
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2023-12-31	$13,483,674
Did the plan have assets held for investment	2023-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2023-12-31	No
Opinion of an independent qualified public accountant for this plan	2023-12-31	Unqualified
Accountancy firm name	2023-12-31	APRIO LLP
Accountancy firm EIN	2023-12-31	571157523
2022 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-18,790,292
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$13,772,974
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$13,605,102
Value of total corrective distributions	2022-12-31	$24,883
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$23,363,427
Value of total assets at end of year	2022-12-31	$185,942,351
Value of total assets at beginning of year	2022-12-31	$218,505,617
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$142,989
Total interest from all sources	2022-12-31	$66,125
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$3,213,240
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$3,213,240
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$15,342,558
Participant contributions at end of year	2022-12-31	$1,552,587
Participant contributions at beginning of year	2022-12-31	$1,464,946
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$2,247,887
Administrative expenses (other) incurred	2022-12-31	$142,989
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-32,563,266
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$185,942,351
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$218,505,617
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$91,180,638
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$121,929,004
Interest on participant loans	2022-12-31	$66,125
Value of interest in common/collective trusts at end of year	2022-12-31	$93,207,670
Value of interest in common/collective trusts at beginning of year	2022-12-31	$95,111,667
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-30,129,829
Net investment gain or loss from common/collective trusts	2022-12-31	$-15,303,255
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$5,772,982
Employer contributions (assets) at end of year	2022-12-31	$1,456
Employer contributions (assets) at beginning of year	2022-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$13,605,102
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	APRIO LLP
Accountancy firm EIN	2022-12-31	571157523
2021 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$46,809,269
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$6,995,550
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$6,857,921
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$20,116,201
Value of total assets at end of year	2021-12-31	$218,505,617
Value of total assets at beginning of year	2021-12-31	$178,691,898
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$137,629
Total interest from all sources	2021-12-31	$70,639
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$11,045,153
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$11,045,153
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$14,111,795
Participant contributions at end of year	2021-12-31	$1,464,946
Participant contributions at beginning of year	2021-12-31	$1,465,011
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$958,704
Administrative expenses (other) incurred	2021-12-31	$137,629
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$39,813,719
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$218,505,617
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$178,691,898
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$121,929,004
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$99,708,761
Interest on participant loans	2021-12-31	$70,639
Value of interest in common/collective trusts at end of year	2021-12-31	$95,111,667
Value of interest in common/collective trusts at beginning of year	2021-12-31	$77,518,126
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$5,157,607
Net investment gain or loss from common/collective trusts	2021-12-31	$10,419,669
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$5,045,702
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$6,857,921
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ARONSON LLC
Accountancy firm EIN	2021-12-31	371611326
2020 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$46,998,426
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$9,061,715
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$8,939,610
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$19,271,415
Value of total assets at end of year	2020-12-31	$178,691,898
Value of total assets at beginning of year	2020-12-31	$140,755,187
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$122,105
Total interest from all sources	2020-12-31	$82,729
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$4,577,626
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$4,577,626
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$12,142,641
Participant contributions at end of year	2020-12-31	$1,465,011
Participant contributions at beginning of year	2020-12-31	$1,392,331
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$2,293,565
Administrative expenses (other) incurred	2020-12-31	$122,105
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$37,936,711
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$178,691,898
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$140,755,187
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$99,708,761
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$75,804,530
Interest on participant loans	2020-12-31	$82,729
Value of interest in common/collective trusts at end of year	2020-12-31	$77,518,126
Value of interest in common/collective trusts at beginning of year	2020-12-31	$63,558,326
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$12,835,172
Net investment gain or loss from common/collective trusts	2020-12-31	$10,231,484
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$4,835,209
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$8,939,610
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	ARONSON LLC
Accountancy firm EIN	2020-12-31	371611326
2019 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$637,589
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$43,563,387
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$8,787,242
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$8,669,839
Value of total corrective distributions	2019-12-31	$2,002
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$17,143,422
Value of total assets at end of year	2019-12-31	$140,755,187
Value of total assets at beginning of year	2019-12-31	$105,341,453
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$115,401
Total interest from all sources	2019-12-31	$66,393
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$2,487,662
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$2,487,662
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$10,623,480
Participant contributions at end of year	2019-12-31	$1,392,331
Participant contributions at beginning of year	2019-12-31	$1,177,615
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$2,427,259
Administrative expenses (other) incurred	2019-12-31	$115,401
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$34,776,145
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$140,755,187
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$105,341,453
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$75,804,530
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$54,545,634
Interest on participant loans	2019-12-31	$66,393
Value of interest in common/collective trusts at end of year	2019-12-31	$63,558,326
Value of interest in common/collective trusts at beginning of year	2019-12-31	$49,618,204
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$13,455,706
Net investment gain or loss from common/collective trusts	2019-12-31	$10,410,204
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$4,092,683
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$8,669,839
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	ARONSON LLC
Accountancy firm EIN	2019-12-31	371611326
2018 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$8,377,772
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$12,395,231
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$12,270,206
Value of total corrective distributions	2018-12-31	$7,675
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$14,798,988
Value of total assets at end of year	2018-12-31	$105,341,453
Value of total assets at beginning of year	2018-12-31	$109,358,912
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$117,350
Total interest from all sources	2018-12-31	$55,439
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$4,376,984
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$4,376,984
Administrative expenses professional fees incurred	2018-12-31	$10,500
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$9,819,421
Participant contributions at end of year	2018-12-31	$1,177,615
Participant contributions at beginning of year	2018-12-31	$1,095,086
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$1,157,442
Administrative expenses (other) incurred	2018-12-31	$106,850
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-4,017,459
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$105,341,453
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$109,358,912
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$54,545,634
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$57,329,625
Interest on participant loans	2018-12-31	$55,439
Value of interest in common/collective trusts at end of year	2018-12-31	$49,618,204
Value of interest in common/collective trusts at beginning of year	2018-12-31	$50,934,201
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-8,039,651
Net investment gain or loss from common/collective trusts	2018-12-31	$-2,813,988
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$3,822,125
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$12,270,206
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	ARONSON LLC
Accountancy firm EIN	2018-12-31	371611326
2017 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$32,301,127
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$7,298,741
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$7,153,163
Value of total corrective distributions	2017-12-31	$437
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$14,929,239
Value of total assets at end of year	2017-12-31	$109,358,912
Value of total assets at beginning of year	2017-12-31	$84,356,526
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$145,141
Total interest from all sources	2017-12-31	$41,688
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$3,132,450
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$3,132,450
Administrative expenses professional fees incurred	2017-12-31	$4,500
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$9,087,268
Participant contributions at end of year	2017-12-31	$1,095,086
Participant contributions at beginning of year	2017-12-31	$1,052,065
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$2,059,769
Administrative expenses (other) incurred	2017-12-31	$140,641
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$25,002,386
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$109,358,912
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$84,356,526
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$57,329,625
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$66,232,207
Interest on participant loans	2017-12-31	$41,688
Value of interest in common/collective trusts at end of year	2017-12-31	$50,934,201
Value of interest in common/collective trusts at beginning of year	2017-12-31	$17,072,254
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$11,717,679
Net investment gain or loss from common/collective trusts	2017-12-31	$2,480,071
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$3,782,202
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$7,153,163
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	Yes
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	ARONSON LLC
Accountancy firm EIN	2017-12-31	371611326
2016 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$19,456,901
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$7,421,583
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$7,310,652
Expenses. Certain deemed distributions of participant loans	2016-12-31	$-6,344
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$13,206,207
Value of total assets at end of year	2016-12-31	$84,356,526
Value of total assets at beginning of year	2016-12-31	$72,321,208
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$117,275
Total interest from all sources	2016-12-31	$54,384
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$903,515
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$903,515
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$8,753,173
Participant contributions at end of year	2016-12-31	$1,052,065
Participant contributions at beginning of year	2016-12-31	$973,632
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$972,489
Other income not declared elsewhere	2016-12-31	$93
Administrative expenses (other) incurred	2016-12-31	$117,275
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$12,035,318
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$84,356,526
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$72,321,208
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$66,232,207
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$58,359,906
Interest on participant loans	2016-12-31	$54,384
Value of interest in common/collective trusts at end of year	2016-12-31	$17,072,254
Value of interest in common/collective trusts at beginning of year	2016-12-31	$12,987,670
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$4,074,760
Net investment gain or loss from common/collective trusts	2016-12-31	$1,217,942
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$3,480,545
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$7,310,652
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-12-31	Yes
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	ARONSON LLC
Accountancy firm EIN	2016-12-31	371611326
2015 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$13,295,345
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$4,089,576
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$3,924,080
Expenses. Certain deemed distributions of participant loans	2015-12-31	$6,344
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$13,351,313
Value of total assets at end of year	2015-12-31	$72,321,208
Value of total assets at beginning of year	2015-12-31	$63,115,439
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$159,152
Total interest from all sources	2015-12-31	$33,591
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$821,987
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$821,987
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$8,889,023
Participant contributions at end of year	2015-12-31	$973,632
Participant contributions at beginning of year	2015-12-31	$742,815
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$937,885
Other income not declared elsewhere	2015-12-31	$365
Administrative expenses (other) incurred	2015-12-31	$159,152
Total non interest bearing cash at beginning of year	2015-12-31	$10,052
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$9,205,769
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$72,321,208
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$63,115,439
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$58,359,906
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$52,012,671
Interest on participant loans	2015-12-31	$33,591
Value of interest in common/collective trusts at end of year	2015-12-31	$12,987,670
Value of interest in common/collective trusts at beginning of year	2015-12-31	$10,349,901
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-1,074,731
Net investment gain or loss from common/collective trusts	2015-12-31	$162,820
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$3,524,405
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$3,924,080
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	ARONSON, LLC
Accountancy firm EIN	2015-12-31	371611326
2014 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$16,346,697
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$4,021,379
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$3,876,326
Value of total corrective distributions	2014-12-31	$6,887
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$12,325,205
Value of total assets at end of year	2014-12-31	$63,115,439
Value of total assets at beginning of year	2014-12-31	$50,790,121
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$138,166
Total interest from all sources	2014-12-31	$34,150
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$3,017,497
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$3,017,497
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$7,941,951
Participant contributions at end of year	2014-12-31	$742,815
Participant contributions at beginning of year	2014-12-31	$712,043
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$1,281,601
Other income not declared elsewhere	2014-12-31	$-6
Administrative expenses (other) incurred	2014-12-31	$138,166
Total non interest bearing cash at end of year	2014-12-31	$10,052
Total non interest bearing cash at beginning of year	2014-12-31	$7
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$12,325,318
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$63,115,439
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$50,790,121
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$52,012,671
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$42,540,513
Interest on participant loans	2014-12-31	$34,150
Value of interest in common/collective trusts at end of year	2014-12-31	$10,349,901
Value of interest in common/collective trusts at beginning of year	2014-12-31	$7,537,558
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$253,203
Net investment gain or loss from common/collective trusts	2014-12-31	$716,648
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$3,101,653
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$3,876,326
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	ARONSON LLC
Accountancy firm EIN	2014-12-31	371611326
2013 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$18,402,133
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$2,141,142
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$1,972,017
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$10,162,846
Value of total assets at end of year	2013-12-31	$50,790,121
Value of total assets at beginning of year	2013-12-31	$34,529,130
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$169,125
Total interest from all sources	2013-12-31	$20,275
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$1,954,209
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$1,954,209
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$6,485,180
Participant contributions at end of year	2013-12-31	$712,043
Participant contributions at beginning of year	2013-12-31	$366,133
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$1,158,901
Other income not declared elsewhere	2013-12-31	$1,290
Administrative expenses (other) incurred	2013-12-31	$169,125
Total non interest bearing cash at end of year	2013-12-31	$7
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$16,260,991
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$50,790,121
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$34,529,130
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$42,540,513
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$27,888,604
Interest on participant loans	2013-12-31	$20,275
Value of interest in common/collective trusts at end of year	2013-12-31	$7,537,558
Value of interest in common/collective trusts at beginning of year	2013-12-31	$6,274,393
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$5,326,935
Net investment gain or loss from common/collective trusts	2013-12-31	$936,578
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$2,518,765
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$1,972,017
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	ARONSON LLC
Accountancy firm EIN	2013-12-31	371611326
2012 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$11,793,361
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$2,475,408
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$2,325,994
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$8,310,868
Value of total assets at end of year	2012-12-31	$34,529,130
Value of total assets at beginning of year	2012-12-31	$25,211,177
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$149,414
Total interest from all sources	2012-12-31	$12,946
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$635,622
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$635,622
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$5,101,233
Participant contributions at end of year	2012-12-31	$366,133
Participant contributions at beginning of year	2012-12-31	$290,025
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$1,166,808
Other income not declared elsewhere	2012-12-31	$6
Administrative expenses (other) incurred	2012-12-31	$149,414
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$9,317,953
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$34,529,130
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$25,211,177
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$27,888,604
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$19,797,330
Interest on participant loans	2012-12-31	$12,946
Value of interest in common/collective trusts at end of year	2012-12-31	$6,274,393
Value of interest in common/collective trusts at beginning of year	2012-12-31	$5,123,822
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$2,463,150
Net investment gain or loss from common/collective trusts	2012-12-31	$370,769
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$2,042,827
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$2,325,994
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	ARONSON LLC
Accountancy firm EIN	2012-12-31	371611326
2011 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total transfer of assets from this plan	2011-12-31	$2,416,252
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$6,190,543
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$925,138
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$813,727
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$6,669,072
Value of total assets at end of year	2011-12-31	$25,211,177
Value of total assets at beginning of year	2011-12-31	$22,362,024
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$111,411
Total interest from all sources	2011-12-31	$10,325
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$170,387
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$170,387
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$4,451,062
Participant contributions at end of year	2011-12-31	$290,025
Participant contributions at beginning of year	2011-12-31	$183,167
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$437,921
Other income not declared elsewhere	2011-12-31	$99,992
Administrative expenses (other) incurred	2011-12-31	$111,411
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$5,265,405
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$25,211,177
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$22,362,024
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$19,797,330
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$20,787,643
Interest on participant loans	2011-12-31	$10,325
Value of interest in common/collective trusts at end of year	2011-12-31	$5,123,822
Value of interest in common/collective trusts at beginning of year	2011-12-31	$1,391,214
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-801,778
Net investment gain or loss from common/collective trusts	2011-12-31	$42,545
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$1,780,089
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$813,727
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	ARONSON LLC
Accountancy firm EIN	2011-12-31	371611326
2010 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$419
Total income from all sources (including contributions)	2010-12-31	$7,931,311
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$925,552
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$848,642
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$5,360,974
Value of total assets at end of year	2010-12-31	$22,362,024
Value of total assets at beginning of year	2010-12-31	$15,356,684
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$76,910
Total interest from all sources	2010-12-31	$5,071
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$155,512
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$155,512
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$3,457,135
Participant contributions at end of year	2010-12-31	$183,167
Participant contributions at beginning of year	2010-12-31	$90,417
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$520,964
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$419
Other income not declared elsewhere	2010-12-31	$38,770
Administrative expenses (other) incurred	2010-12-31	$76,910
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$7,005,759
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$22,362,024
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$15,356,265
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$20,787,643
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$14,233,339
Interest on participant loans	2010-12-31	$5,071
Value of interest in common/collective trusts at end of year	2010-12-31	$1,391,214
Value of interest in common/collective trusts at beginning of year	2010-12-31	$1,032,928
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$2,201,017
Net investment gain or loss from common/collective trusts	2010-12-31	$169,967
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$1,382,875
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$848,642
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	ARONSON LLC
Accountancy firm EIN	2010-12-31	371611326
2009 : UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN

2023: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2023 form 5500 responses
2023-01-01	Type of plan entity	Single employer plan
2023-01-01	Plan funding arrangement – Trust	Yes
2023-01-01	Plan benefit arrangement - Trust	Yes
2022: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: UNITED THERAPEUTICS CORPORATION EMPLOYEES' RETIREMENT PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	UNITED THERAPEUTICS CORPORATION
Employer identification number (EIN):	521984749
NAIC Classification:	541700

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	2638178